ListarArtículos (Farmacología) por materia "lipid-lowering drugs"
Mostrando ítems 1-1 de 1
-
Artículo
Potential interactions between pangenotypic direct-acting antivirals and concomitant cardiovascular therapies in patients with chronic hepatitis C virus infection
(SAGE Publications, 2020)To identify potential drug interactions (DIs) between pangenotypic direct-acting antivirals (pDAAs) and concomitant cardiovascular (CV) therapies in patients with chronic hepatitis C (CHC).